1Dept. of Internal Medicine, Sahlgren's Hospital, Göteborg, Sweden.
Low-dose erythromycin effectively induces phase-III-like motility, mimicking natural migrating motor complex patterns. This gastrointestinal prokinetic agent shows potential for therapeutic applications in motility disorders.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: